Date Hour Room Track
28th November,2017 9.30 am 11.00 am Salon Madrid 3 Track 1

How does the specific context of rare diseases (including fast-track status, low prevalence score) work in favour of long-lasting and shared partnerships between start-ups, pharmas, academia, regulatory bodies and patient organisations?

Wendy White - Global Genes | Wendy White consulting
Fiona Nielsen - Repositive
Ward Capoen - V-Bio Ventures
Olaf Ritzeler - Sanofi
Yann Hérault - Institut Clinique de la Souris

Continue your tour